A Study to Compare Oral Formulations of Tedizolid Phosphate in Healthy Adults (MK-1986-044)

Completed · Phase 1

Conditions studied: Healthy

In brief

The goal of the study is to learn what happens to different oral formulations of tedizolid phosphate (MK-1986) in a healthy person's body over time. Researchers want to know if there is a difference in the oral formulations absorption and elimination from the healthy persons body.

Key facts

Study ID

NCT06609161

Run by

Merck Sharp & Dohme LLC

People needed

18

Starts

2024-07-16

Expected to finish

2024-08-08

Last updated by the study team

2024-09-27

Who can join

Age: 19 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• The key inclusion criteria include but are not limited to the following:
• Has body mass index (BMI) ≥ 18.0 and ≤ 32.0 kg/m\^2

You may not qualify if…

• The key exclusion criteria include but are not limited to the following:
• Has a history of or presence of risk factors for Torsades de Pointes (e.g., heart failure/cardiomyopathy or family history of long QT syndrome), or uncorrected hypokalemia or hypomagnesemia
• Has a history of clostridium difficile-associated diarrhea

Where it is running

• Celerion (Site 0001) — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.